The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment

Hepatobiliary and Pancreatic Diseases International

Volumn 6, Issue 5, 2007, Pages 492-496

  Yu, Jian Wu ^a   Wang, Gui Qiang ^b   Zhao, Yong Hua ^a   Sun, Li Jie ^a   Wang, Shu Qin ^a   Li, Shu Chen ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Model for end stage liver disease; Mortality; Plasma exchange; Severe hepatitis

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; DEXAMETHASONE; ELECTROLYTE; GLUCONATE CALCIUM; HEPARIN; INFUSION FLUID; LAMIVUDINE; PROSTAGLANDIN E; PROTHROMBIN; SCATTER FACTOR;

ACID BASE BALANCE; ADULT; ARTICLE; BACTERIAL PERITONITIS; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS; HEPATORENAL SYNDROME; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LIVER FAILURE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLASMA; PLASMAPHERESIS; PREDICTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VITAMIN SUPPLEMENTATION;

ADULT; CHINA; CHRONIC DISEASE; CREATININE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS; HUMANS; MALE; MIDDLE AGED; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34948872089     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Marrero J, Martinez FJ, Hyzy R. Advances in critical care hepatology. Am J Respir Crit Care Med 2003;168:1421-1426.
2. Poison J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179-1197.
3. Ho DW, Fan ST, To J, Woo YH, Zhang Z, Lau C, et al. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut 2002;50:869-876.
4. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology 2001;33:473-475.
5. Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association. The programme of prevention and cure for viral hepatitis. Zhonghua Chuan Ran Bing Za Zhi 2001;19: 56-62.
6. Artificial Liver Group Chinese Association of Infectious and Parasitic Diseases. Operating guide for artificial liver support system. Zhonghua Gan Zang Bing Za Zhi 2002;10: 329-332.
7. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
8. Mullin EJ, Metcalfe MS, Maddern GJ. Artificial Liver Support: potential to retard regeneration? Arch Surg 2004;139:670-677.
9. Nakae H, Yonekawa T, Narita K, Endo S. Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? Res Commun Mol Pathol Pharmacol 2001;109: 65-72.
10. Nakamura T, Ushiyama C, Suzuki S, Shimada N, Ebihara I, Suzaki M, et al. Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis. Blood Purif 2000;18:50-54.
11. Shang J, Jia BL, Zhang HP, Chen P, Jin X. Effects of artificial liver support system on chronic sever hepatitis patients. Zhonghua Gan Zang Bing Za Zhi 2003;11:506.
12. Li L, Yang Q, Huang J, Xu X, Chen Y, Chen Y, et al. Treatment of hepatic failure with artificial liver support system. Chin Med J (Engl) 2001;114:941-945.
13. Fejfar T, Safka V, Hulek P, Vanasek T, Krajina A, Jirkovsky V. MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS. Vnitr Lek 2006; 52:771-776.
14. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851-858.
15. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005;41:353-358.
16. Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 2006;12:65-71.
17. Yu JW, Wang GQ, Li SC. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol 2006;21:1519-1524.